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ABSTRACT
Background: Pregnancies at the extremes of maternal age (<20 and >35) are associated with
adverse obstetric and perinatal outcomes.There is limited evidence regarding the inﬂuence of
maternal age on serious neonatal outcomes by mode of delivery. The aim of this study thus was to
assess the relaonship between maternal age and mode of delivery and its impact on a composite
of serious neonatal outcomes.
Methods: This was a retrospecve cohort study of low risk women birthing at term in Australia’s
largest maternity hospital over a 7-year period. Intrapartum and perinatal outcomes were
collated and a composite of severe adverse neonatal outcomes (SANO) was generated. Mulple
regression was applied to adjust for confounders and generate adjusted odds raos for the risk
of SANO according to mode of delivery and maternal age.
Results: A total of 84,698 women were included in this study of which 1,572 (1.9%) were aged <20
years, 7,471 (8.8%) were aged 20-24 years, 20,125 (23.8%) were aged 25-29 years, 31,594 (37.3%)
were aged 30-34 years, 19,371 (22.9%) were aged 35-40 years, 4,280 (5.1%) were aged 40-44
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years and 285 (0.3%) were aged ≥45 years. The incidence of SANO was signiﬁcantly greater among
adolescents compared to all other age groups. Overall, SANO was most likely to occur following
EmCS for severe intrapartum hemorrhage/uterine rupture compared to all other indicaons.
Instrumental delivery was associated with the greatest odds of SANO (aOR 3.31, 95%CI 3.08-3.55,
p<0.001) whilst SVD was associated with the lowest odds (aOR 0.46, 95%CI 0.43-0.48, p<0.001).
The adjusted odds for SANO was lowest in women aged 30-34 years (aOR 0.92, 95%CI 0.87-0.97,
p<0.001). The odds of SANO following an SVD increased with maternal age, with women aged
40-44 years having the highest odds. Similarly, the odds of SANO following an instrumental
delivery increased with maternal age (age <20 years: aOR 2.21, 95%CI 1.38-3.54, p<0.001 vs. age
35-39 years: aOR 3.76, 95%CI 3.16-4.48, p<0.001).
Conclusion: This large retrospecve cohort study has demonstrated that maternal age not only
aﬀects the mode of delivery and the incidence of adverse neonatal outcomes but that the eﬀect
of mode of delivery upon the risk of SANO is not independent of maternal age.
Keywords: adolescent pregnancy; advanced maternal age; adverse outcomes; mode of birth
INTRODUCTION
Over the last 40 years, greater availability of contracepon, the use of arﬁcial reproducve
technology (ART) and major changes in lifestyle, workforce and populaon demographics
have resulted in women delaying pregnancy unl later in life, parcularly in high income
countries.1,2 Advanced maternal age (commonly deﬁned as age >35 years)3-5 is known to be
associated with adverse obstetric and perinatal outcomes including miscarriage, congenital
anomalies, gestaonal diabetes, hypertensive disorders, placental abrupon, caesarean delivery
and perinatal death, even aer adjusng confounders.6-11 Concurrent with the increased
obstetric and perinatal risks seen in older women, adolescents (age <20 years) are also at similarly
increased risk including fetal growth restricon, preterm birth and perinatal death.12-14 Indeed,
both extremes of reproducve age have increased complicaons compared to pregnancies in
women aged 25-35 years. There is however limited informaon regarding the inﬂuence of
maternal age on serious neonatal outcomes by mode of birth given that both factors inﬂuence
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newborn outcomes. The aim of this study thus was to assess the relaonship between maternal
age and mode of delivery and its impact on serious neonatal outcomes.
METHODS
This was a retrospecve cohort study of low risk women birthing at term (>37 weeks gestaon)
at the Mater Mothers’ Hospital, Brisbane, between January 2008 and April 2017, using data from
the instuon’s perinatal database. The Mater Mothers’ Hospital is a terary centre and the
largest maternity hospital in Australia with >10,500 births/year. This study was approved by the
hospital’s Human Research Ethics Commiee (Ref no. HREC/14/MHS/37).
All women with a singleton fetus and birthing aer 37+0 weeks gestaon were eligible for
inclusion. Gestaonal age was calculated from either the last menstrual period or the earliest
obstetric ultrasound scan. Exclusion criteria included mulple pregnancy, known genec or
congenital fetal malformaons and birth <37 weeks gestaon. Demographic data collected
including maternal age, BMI, ethnicity (Caucasian, Asian, Aboriginal or Torres Strait Islander
(ATSI) and other), smoking status, alcohol consumpon, diabetes mellitus (gestaonal, Type 1
or 2), hypertension (gestaonal, chronic and pre-eclampsia) and use of assisted reproducve
technologies (ART) and socioeconomic status using the Socio-Economic Index for Areas (SEIFA)
scores. A SEIFA score in lowest quarle represents the most disadvantaged demographic group.15
Intrapartum and perinatal outcomes included gestaon at birth, birth weight, mode of birth and
indicaon if emergency caesarean secon was required. A composite of severe adverse neonatal
outcome (SANO) was deﬁned as: admission to the Neonatal Intensive Care Unit (NICU), severe
acidosis (umbilical artery pH ≤7.0, base excess ≤-12 mmol/L, or lactate >6 mmol/L), 5-minute
Apgar score <3 and perinatal death (deﬁned as sllbirth and neonatal death).
Stascal Analysis
Stascal analysis was performed using Stata SE®, Release 15, for Windows (StataCorp LP,
College Staon, TX, USA). Data was assessed for normality using Shapiro Wilk test. Comparison
between age categories and connuous variables was assessed with the Kruskall-Wallis test.
Associaons between categorical variables were assessed using Person ӽ2 and Fischer’s exact
test as appropriate. Generalised esmang equaons were used to account for the correlaon
between mothers who birthed more than once during the study period. Mulple regression was
applied, adjusng for BMI, ethnicity, nulliparity, diabetes, hypertension, SEIFA score, ART use,
alcohol use, smoking and birthweight, to generate adjusted odds raos (aOR). P values <0.05
were considered signiﬁcant. Summary stascs were reported as mean (standard deviaon [SD])
if normally distributed and median (interquarle range [IQR]) if non-normally distributed.
RESULTS
A total of 84,698 women were included in this study of which 1,572 (1.9%) were aged <20 years,
7,471 (8.8%) were aged 20-24 years, 20,125 (23.8%) were aged 25-29 years, 31,594 (37.3%) were
aged 30-34 years, 19,371 (22.9%) were aged 35-40 years, 4,280 (5.1%) were aged 40-44 years and
285 (0.3%) were aged ≥45 years. There was a stascally signiﬁcant diﬀerence in BMI across the
age groups with older women trending towards a higher BMI than their younger contemporaries.
Adolescents had a lower median SEIFA score compared to all other age groups. Women aged
<30 years were more likely to be nulliparous and smokers whilst those ≥30 years were more
likely to have diabetes mellitus, hypertension, consume alcohol in pregnancy and required ART
to conceive. (Table1).
The incidence of spontaneous vaginal delivery was signiﬁcantly higher in adolescents compared
to all other age groups whilst women >40 years were more likely to undergo an elecve
caesarean (ElCS). Although rates of emergency caesarean (EmCS) increased with maternal age
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the indicaons for EmCS diﬀered signiﬁcantly - women aged <20 years were more likely to have
an EmCS for non-reassuring fetal status (NRFS) than any other age group. (Table 2)
The incidence of all adverse neonatal outcomes was highest amongst adolescents and lowest
generally lowest amongst those aged 30-34. The incidence of the composite SANO was
signiﬁcantly greater among adolescents compared to all other age groups (Table 2) and was most
likely to occur following EmCS for severe intrapartum hemorrhage/uterine rupture compared to
all other indicaons. (Table 3)
Overall instrumental delivery was associated with the greatest odds of SANO (aOR 3.31, 95%CI
3.08-3.55, p<0.001) whilst SVD was associated with the lowest odds (aOR 0.46, 95%CI 0.43-0.48,
p<0.001). Aer controlling for confounders idenﬁed on univariate analysis the adjusted odds
for SANO was lowest in women aged 30-34 years (aOR 0.92, 95%CI 0.87-0.97, p<0.001). (Table
4).
The odds of SANO following an SVD increased with maternal age, with women aged 40-44 years
having the highest odds (aOR 0.72, 95%CI 0.55-0.94, p<0.001). Similarly the odds of adverse
neonatal outcome following an instrumental delivery generally increased with maternal age (age
<20 years: aOR 2.21, 95%CI 1.38-3.54, p<0.001 vs. age 35-39 years: aOR 3.76, 95%CI 3.16-4.48,
p<0.001). At the extremes of maternal age (<20 years and >45 years) EmCS conferred the highest
odds for SANO (age <20 years: aOR 2.74, 95%CI 1.68-4.36, p<0.001 and age >45 years: aOR 5.26,
95%CI 2.54-10.89, p<0.001). Conversely for women <45 years, instrumental birth carried the
highest odds of adverse neonatal outcome. The odds for SANO following EmCS for NRFS increased
with increasing maternal age.
DISCUSSION
Principal ﬁndings and implicaons for pracce
This large study has shown that the incidence of SANO is highest in adolescents although the
overall odds for adverse outcome aer adjusng for confounders is highest in the 25-29 years
cohort (aOR 1.13, 95%CI 1.06-1.20) and lowest in women aged 30-34 years (aOR 0.92, 95%CI
0.81-0.97). Our ﬁndings of an increased incidence of SANO in adolescents is in keeping with other
studies showing that pregnancy in this age group is associated with increased adverse maternal
and perinatal outcomes.12,13,16 Whilst sociodemographic factors including smoking, illicit drug
use and poor engagement with antenatal services, are felt to be parally responsible for the
increased risks seen in this group17,18 it has also been hypothesised that biological factors are at
play including inadequate uterine blood ﬂow as well as a deﬁciency in available nutrients for the
fetus due to ongoing maternal growth.19-22
Advanced maternal age (>35 years) has previously been shown to be associated with
adverse obstetric and neonatal outcomes including caesarean delivery and sllbirth. Older
women are more likely to have pre-exisng medical co-morbidies such as diabetes and
hypertension, more likely to have undergone ART, are pre-disposed to increased endothelial
damage and poor placentaon as well as being prone to poorer adaptaon to the increased
haemodynamic demands of pregnancy.9,23-25 Controversy remains regarding the hypothesis of
poorer placentaon as a factor for poorer outcomes; one study demonstrated that maternal age
was not associated with increased uteroplacental insuﬃciency or increased rates of intrauterine
growth restricon among sll births.11 Our ﬁndings of reduced rates of EmCS for NRFS in older
women is not consistent with the poor placentaon hypothesis as diminished placental funcon
generally predisposes a fetus to intrapartum fetal distress. 26 Increased caesarean secon rates
in this older populaon have previously been aributed to several factors including poorer
myometrial funcon with increasing age resulng in higher rates of failure to progress and
instrumental delivery, 27,28 increased incidence of uterine malformaons/leiomyoma as well as
clinician preference due to a percepon of these pregnancies being more “precious”. Whilst
our data conﬁrms increasing rates of emergency and elecve caesarean secons with increasing
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maternal age, we have failed to demonstrate higher rates of EmCS for failure to progress in older
women in contrast to previous publicaons.28,29 A 2013 scienﬁc impact paper by the RCOG,
UK idenﬁed a lack of evidence regarding the eﬀect of maternal age upon failed instrumental
delivery rates.30 Our results however show that that failed instrumentaon as an indicaon
for EmCS declined signiﬁcantly from the age of 20 but when it did occur, it had the strongest
associaon with SANO across all age groups.
Strengths and Limitaons
The strengths of this study are the large numbers from a single centre with detailed pregnancy
outcome data. The limitaons relate mainly to its retrospecve nature and potenal imprecision
for the indicaons of emergency operave delivery. The terary focus of our study may also not
be enrely reﬂecve of a low risk cohort.
To our knowledge, only one previous publicaon speciﬁcally assessed the eﬀect of maternal
age upon the incidence of uteroplacental insuﬃciency as a possible mechanism for these
increased risks. In recent years the use of the cerebroplacental rao (CPR) (rao of middle
cerebral artery pulsality index to umbilical artery pulsality index) has been shown to be
predicve for intrapartum fetal compromise and emergency operave delivery and poor
neonatal outcomes.26,31-34 A future avenue for assessing the mechanism for maternal age
aﬀecng adverse perinatal outcomes should include analysis of the eﬀect of maternal age upon
the fetal CPR.
Conclusion
This large retrospecve cohort study has demonstrated that maternal age not only aﬀects the
mode of delivery and the incidence of adverse neonatal outcomes but that the eﬀect of mode of
delivery upon the risk of SANO is not independent of maternal age. In women at the extremes of
maternal age (<20 years and >45 years) EmCS conferred the greatest odds of poor outcome whilst
for other age categories instrumental delivery was the greatest risk factor. Our results suggest
that strategies for beer idenﬁcaon of women that may require emergency operave birth in
these age categories is required.
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Table 1: Maternal Demographics
Maternal
Age
<20 20-24 25-29 30-34 35-39 40-44 >45 P
value
Total
populaon
1.9%
(1,572/84,698)
8.8%
(7,471/84,698)
23.8%
(20,125/84,698)
37.3%
(31,594/84,698)
22.9%
(19,371/84,698)
5.1%
(4,280/84,698)
0.3%
(285/84,698)
BMI (Kg/
m2)§
21.9
(19.5 – 25.4)
22.9
(20.1 – 27.3)
22.7
(20.3 – 26.3)
22.7
(20.4 – 25.9)
23.1
(20.8 – 26.5)
23.8
(21.3 – 27.6)
24.2
(21.5 –
27.9)
<0.001
Ethnicity*
Caucasian 58.5%
(919/1,571)
60.9%
(4,545/7,458)
63.1%
(12,682/20,098)
71.1%
(22,440/31,563)
75.7%
(14,637/19,338)
76.5%
(3,272/4,277)
74.7%
(213/285)
<0.001
ATSI 14.8%
(232/1,571)
6.1%
(456/7,458)
2.1%
(412/20,098)
1.0%
(300/31,563)
0.9%
(169/19,338)
1.2%
(53/4,277)
0.7%
(2/285)
<0.001
Asian 3.4%
(53/1,571)
10.8%
(806/7,458)
21.0%
(4,216/20,098)
18.6%
(5,883/31,563)
14.9%
(2,874/19,338)
12.5%
(533/4,277)
14.0%
(40/285)
<0.001
Other 23.4%
(367/1,571)
22.1%
(1,651/7,458)
13.9%
(2,788/20,098)
9.3%
(2,940/31,563)
8.6%
(1,658/19,338)
9.8%
(419/4,277)
10.5%
(30/285)
<0.001
SEIFA Score 1,014
(925 –
1,055)
1,039
(960 –
1,062)
1,044
(996 –
1,079)
1,055
(1,024 –
1,085)
1,070
(1,027 –
1,085)
1,070
(1,026 –
1,085)
1,055
(997 –
1,085)
<0.001
Nulliparous* 85.6%
(1,345/1,572)
61.8%
(4,616/7,465)
58.3%
(11,728/20,120)
45.0%
(14,205/31,588)
30.7%
(5,952/19,362)
28.9%
(1,238/4,278)
37.9%
(108/285)
<0.001
ART 0.1%
(1/1,572)
0.6%
(45/7,471)
3.1%
(622/20,125)
5.2%
(1,649/31,594)
9.0%
(1,735/19,371)
15.0%
(641/4,280)
30.5%
(87/285)
<0.001
Diabetes* 1.9%
(30/1,572)
4.2%
(316/7,471)
6.2%
(1,251/20,125)
7.6%
(2,398/31,594)
9.8%
(1,893/19,371)
12.5%
(533/4,280)
14.7%
(42/285)
<0.001
Hypertension*3.2%
(51/1,572)
5.0%
(370/7,471)
5.2%
(1,046/20,125)
5.5%
(1,721/31,594)
6.6%
(1,271/19,371)
9.0%
(384/4,280)
10.9%
(31/285)
<0.001
Alcohol* 3.9%
(61/1,572)
3.2%
(241/7,471)
3.2%
(642/20,125)
4.4%
(1,387/31,594)
5.4%
(1,048/19,371)
6.5%
(277/4,280)
4.9%
(14/285)
<0.001
Smoking* 48.3%
(759/1,572)
31.5%
(2,355/7,471)
17.3%
(3,473/20,125)
12.4%
(3,931/31,594)
12.4%
(2,406/19,371)
12.0%
(515/4,280)
8.4%
(24/285)
<0.001
BMI: Body Mass Index; ATSI: Aboriginal or Torres Strait Islander; ART: Assisted Reproducve
Technologies; SEIFA: Socio-Economic Indexes for Areas; ART: Assisted Reproducve Technologies *% (n)
Chi Square test, §Median (interquarle Range), Kruskal Wallis
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Table 2: Obstetric Outcomes
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Maternal Age,
years
Total <20 20-24 25-29 30-34 35-39 40-44 ≥45 P
value
n. 84698 1572 7470 20125 31594 19371 4280 285
Gestaon at
delivery,
weeks §
39 (38-40) 39 (38 –
40)
39 (38 –
40)
39 (38 –
40)
39 (38 –
40)
39 (38 –
40)
38 (38 –
39)
38 (37 –
39)
<0.001
Birth Weight 3,392
(3,062/3,720)
3,315
(2,925/3,662)
3,380
(3,040/3,730)
3,392
(3,050/3,720)
3,410
(3,089/3,724)
3,390
(3,068/3,725)
3,348
(3,022/3,675)
3,270
(2,930/3,580)
<0.001
Mode of delivery
SVD 51.0%
(43,234/84,698)
71.4%
(1,123/1,572)
65.0%
(4,855/7,471)
55.4%
( 1,145/20,125)
49.4%
(15,621/31,594)
45.4%
(8,795/19,371)
37.9%
(1,623/4,280)
24.9%
(71/285)
<0.001
Instrumental
Delivery
13.1%
(11,115/84,698)
11.9%
(187/1,572)
12.3%
(918/7,471)
15.7%
(3,152/20,125)
14.4%
(4,535/31,594)
10.2%
(1,980/19,371)
7.7%
(329/4,280)
4.9%
(14/285)
<0.001
Forceps 3.1%
(2,588/84,698)
2.5%
(39/1,572)
2.7%
(199/7,471)
3.9%
(791/20,125)
3.3%
(1,040/31,594)
2.3%
( 42/19,371)
1.8%
(76/4,280)
0.4%
(1/285)
<0.001
Ventouse 10.1%
(8,527/84,698)
9.4%
(148/1,572)
9.6%
(719/7,471)
11.7%
(2,361/20,125)
11.1%
(3,495/31,594)
7.9%
(1,538/19,371)
5.9%
(253/4,280)
4.6%
(13/285)
<0.001
El CS 19.9%
(16850/84,698)
2.2%
(34/1,572)
6.7%
(501/7,471)
12.5%
(2,512/20,125)
20.3%
(6,398/31,594)
29.1%
(5,641/19,371)
37.8%
(1,619/4,280)
50.9%
(145/285)
<0.001
Em CS 15.9%
(13,499/84,698)
14.5%
(228/1,572)
16.0%
(1,196/7,471)
16.5%
(3,316/20,125)
16.0%
( ,040/31,594)
15.3%
(2,955/19,371)
16.6%
(709/4,280)
19.3%
(55/285)
0.01
Indication for Em CS
NRFS* 28.8%
(3,419/11,864)
46.4%
(104/224)
30.4%
(336/1,106)
29.5%
(886/3,008)
28.9%
(1,273/4,401)
26.7%
(659/2,473)
25.1%
(152/605)
19.2%
(9/47)
<0.001
FTP* 35.3%
(4,188/11,864)
26.8%
(60/224)
36.0%
(398/1,106)
38.2%
(1,148/3,008)
36.0%
(1,586/4,401)
33.0%
(817/2,473)
28.4%
(172/605)
14.9%
(7/47)
<0.001
Cord
Presentations#
0.9%
(102/11,864)
1.8%
(4/224)
0.6%
(7/1,106)
0.8%
(25/3,008)
0.9%
(39/4,401)
0.9%
(23/2,473)
0.7%
(4/605)
0%
(0/47)
NS
Haemorrhage/
Uterine
Rupture*
4.7%
(553/11,864)
2.2%
(5/224)
3.6%
(40/1,106)
3.6%
(109/3,008)
4.7%
(205/4,401)
6.0%
(148/2,473)
7.3%
(44/605)
4.3%
(2/47)
<0.001
Malpresentation*9.9%
(1,177/11,864)
8.0%
(18/224)
10.4%
(115/1,106)
9.6%
(289/3,008)
9.8%
(429/4,401)
10.3%
(254/2,473)
10.6%
(64/605)
17.0%
(8/47)
NS
Failed
Instrumentation*
2.8%
(330/11,864)
2.2%
(5/224)
3.5%
(39/1,106)
3.2%
(95/3,008)
2.9%
(128/4,401)
2.2%
(54/2,473)
1.5%
(9/605)
0%
(0/47)
<0.05
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Other* 17.7 %
(2,095/11,864)
12.5%
(28/224)
15.5%
(171/1,106)
15.2%
(456/3,008)
16.8%
(741/4,401)
21.0%
(518/2,473)
26.5%
(160/605)
44.7%
(21/47)
<0.001
5-minute Apgar
≤3
0.6%
(490/84,172)
1.7%
(26/1,560)
0.9%
(63/7,410)
0.6%
(111/19,978)
0.5%
(140/31,441)
0.6%
(113/19,249)
0.9%
(36/4,250)
0.4%
(1/284)
<0.001
Acidosis 4.9%
(4,140/84,968)
6.9%
(108/1,572)
6.1%
(453/7,471)
6.2%
(1,237/20,125)
4.6%
(1,461/31,594)
3.7%
(712/19,371)
3.9%
(166/4,280)
1.1%
(3/285)
<0.001
NICU
admission
9.2%
(7,827/84,698)
14.9%
(234/1,572)
11.0%
(822/7,471)
10.0%
(2,018/20,125)
8.2%
(2,578/31,594)
8.8%
(1,694/19,371)
10.4%
(444/4,280)
13.0%
(37/285)
<0.001
IUFD 0.5%
(384/84,654)
1.1%
(17/1,571)
0.6%
(47/7,464)
0.5%
(96/20,119)
0.3%
(105/31,580)
0.5%
(94/19,358)
0.6%
(25/4,277)
0%
(0/285)
<0.001
NND 0.3%
(221/84,272)
0.5%
(7/1,554)
0.5%
(36/7,419)
0.3%
(59/20,023)
0.2%
(57/31,475)
0.3%
(52/19,264)
0.2%
(9/4,252)
0.4%
(1/285)
<0.001
Perinatal Death 0.8%
(647/84,698)
1.6%
(25/1,572)
1.2%
(88/7,471)
0.8%
(161/20,125)
0.6%
(176/31,594)
0.8%
(159/19,371)
0.9%
(37/4,280)
0.4%
(1/285)
<0.001
Severe Adverse
Neonatal Outcome
13.7%
(11,583/84,698)
21.4%
(337/1,572)
16.5%
(1,230/7,471)
15.4%
(3,108/20,125)
12.3%
(3,892/31,594)
12.3%
(2,375/19,371)
14.0%
(600/4,280)
14.4%
(41/285)
<0.001
SVD: Spontaneous Vaginal Delivery; El CS: Elecve Caesarean Secon; EmCS: Emergency Caesarean
Secon; NRFS: Non-Reassuring Fetal Status; FTP: failure to progress; NICU: neonatal intensive care unit;
IUFD: intrauterine fetal demise; NND: neonatal death; Perinatal death: IUFD and NND combined
*Chi Square test # Fishers Exact Test; § Median (Interquarle Range), Kruskal Wallis
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Table 3: Incidence of Severe Adverse Neonatal Outcome according to Mode of Delivery,
by Maternal Age
Maternal
age
Total <20 20-24 25-29 30-34 35-39 40-44 >45
n. 84698 1572 7471 20125 31594 8795 4280 285
SVD 9.3%
(4001/43234)***
16.8%
(189/1123)***
11.4%
(551/4856)
9.9%
(1107/11145)***
8%
(1242/15621)***
8.5%
(745/8795)***
10.2%
(165/1623)***
2.8%
(2/71)#**
Instrumental 24.14
(2683/11115)***
24.6%
(46/187)
25.5%
(234/918)***
26.1%
(824/3152)***
22.7%
(1030/4535)***
23.1%
(457/1980)***
27.4%
(90/329)***
14.3%
(2/14)#
Forceps 28.7%
(742/2588)***
17.95%
(7/39)
33.2%
(66/199)***
27.9%
(221/791)***
29%
(302/1040)***
29%
(128/442)***
23.7%
(18/76)*
0#
Ventouse 22.8%
(1941/8527)***
26.4%
(39/148)
23.4%
(168/719)***
25.5%
(603/2361)
20.8%
(728/3495)***
21.4%
(329/1538)***
28.5%
(72/253)***
15.4%
(2/13)#
Elective CS 8.4%
(1411/16850)***
14.7%
(5/34)#
11.8%
(59/501)*
11%
(275/2512)***
8%
(510/6398)***
7.1%
(400/5641)***
8.9%
(144/1619)***
12.4%
(18/145)
Emergency CS 25.8%
(3488/13499)***
42.5%
(97/228)***
32.3%
(386/1196)***
27.2%
(902/3316)***
22%
(1110/5040)***
26.2%
(773/2955)***
28.4%
(201/709)***
34.6%
(19/55)***
NRFS
30.2%
(1034/3419)***
42.3%
(44/104)
37.8%
(127/336)*
30.4%
(269/886)*
25.9%
(330/1273)**
31.3%
(206/659)*
36.8%
(56/152)*
22.2%
(2/9)#
FTP 9.4%
(394/4188)***
20%
(12/60)
11.6%
(46/398)***
10.6%
(122/1148)***
8%
(127/1586)***
8.7%
(71/817)***
9.3%
(16/172)***
0#
Cord
presentation
47.1%
(48/102)***
50%
(2/4)#
28.6%
(2/7)#
60%
(15/25)***
38.5%
(15/39)*
52.2%
(12/23)*
50%
(2/4)#
0#
Haemorrhage/
uterine
rupture
60.2%
(333/553)***
100%
(5/5)#*
72.5%
(29/40)***
69.7%
(76/109)***
56.6%
(116/205)***
53.4%
(79/148)***
56.1%
(26/44)***
100%
(2/2)#
Malpresentation27.1%
(319/1177)
38.9%
(7/18)
29.6%
(34/115)
29.4%
(85/289)
21.5%
(92/429)
31.1%
(79/254)
28.1%
(18/64)
50%
(4/8)#
Failed
instrumentation
29.4%
(97/330)
40%
(2/5)#
33.3%
(13/39)
32.6%
(31/95)
25%
(32/128)
29.6%
(16/54)
33.3%
(3/9)#
0
Other 46%
(964/2095)***
85.7%
(24/28)#***
66.1%
(113/171)***
51.1%
(233/456)***
39.7%
(294/741)***
45.6%
(236/518)***
33.1%
(53/160)
52.4%
(11/21)
SVD: Spontaneous Vaginal Delivery; El CS: Elecve Caesarean Secon; EmCS: Emergency Caesarean
Secon; NRFS: Non-Reassuring Fetal Status; FTP: failure to progress Percentage (N) Chi Square Test, #
Fishers Exact Test; * p<0.05, **p<0.01, ***p<0.001
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Table 4: Adjusted Odds Rao of Severe Adverse Neonatal Outcome according to Mode
of Birth, by Maternal Age
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Maternal
Age
Total <20 20-24 25-29 30-34 35-39 40-44 >45##
Severe
Adverse
Neonatal
Outcome
0.99
(0.99 –
0.99)*
1.17
(0.98 –
1.38)
0.98
(0.89 – 1.07)
1.13
(1.06 –
1.20)***
0.92
(0.87 –
0.97)**
0.96
(0.90 –
1.02)
1.04
(0.93 – 1.17)
1.09
(0.78 – 1.51)
SVD 0.46
(0.43 –
0.48)***
0.37
(0.26 –
0.51)***
0.38
(0.32 –
0.45)***
0.38
(0.34 –
0.42)***
0.48
(0.44 –
0.53)***
0.59
(0.52 –
0.66)***
0.72
(0.55 –
0.94)*
0.15
(0.03 –
0.63)*
Instrumental 3.31
(3.08 –
3.55)***
2.21
(1.38 –
3.54)**
2.76
(2.21 –
3.46)***
3.49
(3.08 –
3.96)***
3.27
(2.90 –
3.68)***
3.76
(3.16 –
4.48)***
3.43
(2.35 –
5.00)***
1.01
(0.21 – 4.82)
Forceps 3.01
(2.65 –
3.42)***
1.20
(0.39 –
3.72)
3.23
(2.14 –
4.88)***
2.66
(2.14 –
3.32)***
3.23
(2.63 –
3.96)***
3.79
(2.72 –
5.29)***
2.74
(1.14 –
6.56)*
NA
Ventouse 2.84
(2.63 –
3.07)***
2.44
(1.49 –
3.98)***
2.32
(1.81 –
2.98)***
3.09
(2.69 –
3.54)***
2.67
(3.34 –
3.03)***
3.17
(2.63 –
3.84)***
3.33
(2.22 –
4.99)***
1.11
(0.23 – 5.37)
El CS 0.56
(0.52 –
0.59)***
0.63
(0.29 –
1.41)
0.65
(0.47 –
0.91)*
0.60
(0.52 –
0.70)***
0.57
(0.51 –
0.63)***
0.50
(0.44 –
0.57)***
0.53
(0.42 –
0.67)***
0.57
(0.28 – 1.20)
EmCS 1.93
(1.82 –
2.05)***
2.71
(1.68 –
4.36)***
2.22
(1.82 –
2.70)***
1.86
(1.66 –
2.10)***
1.77
(1.60 –
1.97)***
2.10
(1.83 –
2.41)***
1.92
(1.46 –
2.52)***
5.26
(2.54 –
10.89)***
Indication for Emergency Caesarean
NRFS 1.97
(1.74 –
2.24)***
1.21
(0.51 –
2.85)
1.84
(1.23 –
2.73)**
1.90
(1.49 –
2.42)***
1.96
(1.57 –
2.43)***
2.02
(1.50 –
2.71)***
3.19
(1.76 –
5.76)***
0.31
(0.07 – 1.48)
FTP 0.46
(0.40 –
0.53)***
0.72
(0.28 –
1.87)
0.54
(0.35 –
0.84)**
0.46
(0.35 –
0.60)***
0.44
(0.34 –
0.57)***
0.40
(0.28 –
0.58)***
0.49
(0.24 –
1.00)*
NA
Cord
Presentation
2.72
(1.48 –
5.01)**
1.70
(0.15 –
19.80)
1.11
(0.07 –
17.93)
3.30
(1.15 –
9.48)*
2.06
(0.69 –
6.15)
4.65
(1.17 –
18.51)*
2.19
(0.29 –
16.33)
NA
Haemorrhage/
Uterine
Rupture
1.27
(1.01 –
1.61)*
1 1.94
(0.80 – 4.73)
1.15
(0.65 –
2.06)
1.34
(0.93 –
1.93)
1.12
(0.70 –
1.80)
2.05
(0.92 – 4.57)
NA
Malpresentation0.64
(0.53 –
0.77)***
0.14
(0.04 –
0.51)**
0.38
(0.19 –
0.77)**
0.58
(0.40 –
0.85)**
0.63
(0.46 –
0.86)**
0.94
(0.62 –
1.41)
0.56
(0.21 – 1.48)
1.97
(0.40 – 9.65)
Failed
Instrumentation
2.76
(2.02 –
3.78)***
3.90
(0.41 –
36.69)
1.84
(0.71 – 4.80)
2.84
(1.61 –
5.02)***
3.01
(1.80 –
5.02)***
2.89
(1.33 –
6.28)**
4.10
(0.72 –
23.50)
NA
Other 0.91
(0.79
– 1.06)
4.90
(0.77 –
31.19)
1.33
(0.76 – 2.31)
1.07
(0.81 –
1.43)
0.91
(0.72 –
1.17)
0.78
(0.57 –
1.06)
0.46
(0.25 – 0.82)
2.50
(0.73 – 8.49)
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SVD: Spontaneous Vaginal Delivery; El CS: Elecve Caesarean Secon; EmCS: Emergency Caesarean
Secon; NRFS: Non-Reassuring Fetal Status; FTP: Failure To Progress. Adjusted for parity, BMI,
hypertension, diabetes, smoking status, assisted reproducon, birth weight, SEIFA score and gestaonal
age at delivery. ##Adjusted for parity & assisted reproducon *p <0.05, **p<0.01, ***p<0.001.
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